Biotech

All Articles

BioAge eyes $180M coming from IPO, exclusive positioning for obesity trials

.BioAge Labs is eyeing all around $180 million in preliminary proceeds coming from an IPO and a pers...

Merck's LAG-3 combo falls short colon cancer cells phase 3 research study

.A try through Merck &amp Co. to unlock the microsatellite secure (MSS) metastatic colon cancer cell...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Allies has actually finalized a fund of 180 million euros ($ 200 thousand), fund...

BioAge generates $198M coming from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is actually bringing in practically $200 million by means of its own Nasdaq IPO today, ...

Acadia brings BMS veterinarian aboard as chief executive officer-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings as we...

Cassava pays for $40M over presumably deceptive Alzheimer's improve

.Cassava Sciences has consented to spend $40 thousand to address an investigation in to claims it cr...

Merck bags choices on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has actually gotten options on pair of Evaxion Biotech injection prospects, paying f...

Enanta's RSV antiviral crushes virus-like tons in problem research

.Enanta Pharmaceuticals has actually connected its respiratory system syncytial virus (RSV) antivira...

Biogen containers SAGE-324 collaboration after important tremor fail

.Biogen has provided the last ceremonies to its own partnership with Sage Therapies on SAGE-324, jun...

AbbVie Parkinson's medicine from $8.7 B Cerevel acquistion credit ratings

.On the very same day that some Parkinson's ailment medicines are actually being disputed, AbbVie ha...